Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety and Efficacy of Fondaparinux 1,5 mg for the Prevention of Venous Thromboembolism in Medical Patients With Renal Insufficiency

NCT00927602 is registered in ClinicalTrials.gov with Università degli Studi dell'Insubria as lead sponsor.

NCT NCT00927602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00927602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety and Efficacy of Fondaparinux 1,5 mg for the Prevention of Venous Thromboembolism in Medical Patients With Renal Insufficiency
Lead sponsor
Università degli Studi dell'Insubria
Phase
Phase 4
Overall status
Terminated
Start date
April 30, 2009
Completion date
March 31, 2012
Enrollment
206 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

medical patients, renal insufficiency